ArticleDiabetes, obesity & metabolism2025

Concurrent SGLT2 inhibitor use in patients with type 2 diabetes hospitalised for high-dose corticosteroid therapy: Mitigated iatrogenic hyperglycaemia.

Kaori Ikeda et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.